Skip to content

Dr. Thomas Lievens

Active Private limited companyfounded 2021active for 5 yearsKievermont 51, 2440 GeelKBO/BCE: BE 0776.702.061

Lifetime

4 annual accounts with figures on one time axis
peak of €195,617 in 2023
€182,149▼ 0.8%
peak of €134,922 in 2023
€127,350▲ 3.1%
peak of €378,555 in 2024
€2,500▼ 99.3%
€149,449▲ 295%
Board1 name since 2021
1 director
Documentsfilings and deeds
29-06-202632 days before the deadline
2025micro format
Registered office moved within Geel 22-12Dividend €503,405Equity from €378,555 to €2,500Debts from €37,870 to €149,449Cash from €18,846 to €75,074

Key points

from the 2025 annual accounts

Equity

€2,500 from €378,555 in 2024

Equity fell by 99% in 1 year.

Turnover

≈ €330,000 estimated

The micro format states no turnover.

Debts

€149,449 98% of the balance sheet
Financial debts 4%Suppliers 1%Taxes and wages 0%Other 95%

Of this, €142,887 falls due within a year.

Liquidity

0.71 was 16.10 in 2024

Short-term debts rose from €21,581 to €142,887.

Filings

4 annual accounts since 2022
AprilJune31 JulyOctober2022202320242025

The last four annual accounts were filed 20 to 32 days before the end of the period.

Position in the sector

1.6%

Lower solvency than 93% of companies in human health. The sector median is 63.0%, over 21,385 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,154 companies had the same profile as Dr. Thomas Lievens has now. Each dot stands for 6 companies, two years later.

96.0%
were still trading
2.3%
stopped another way
1.7%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,154 companies, not a prediction for Dr. Thomas Lievens. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 250 sharesdeed of 04-11-2021
Board & ownership

Recent changes

Registered office moved within Geel The registered office moved from Zandstraat 43, 2440 Geel to Kievermont 51, 2440 Geel · Board meeting of 03-11-2025 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0776702061
Incorporation Founding capital of €2,500, 250 shares · Founded by · appointed as director · published on 04-11-2021 · Gazette deed
First establishment Nieuwstraat 8, Retie
All 10 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Thomas Lievens Geel €151,949 €182,149 1.6% -
Opsomer-Roegiers Médical Grez-Doiceau €156,110 €180,948 21.8% -
Dr. Delattin Tom Zoutleeuw €161,514 €194,797 96.0% -
Docteur Matthieu JASON Verviers €169,583 €182,379 2.9% -
DR. JOREN HEYMANS Deinze €141,288 €175,854 2.8% -
CENTRE MEDICAL DE JEMEPPE Seraing €150,002 €202,400 -25.4% -
Dr. Wouter Van Tilborg Zonhoven €167,128 €199,203 1.8% -

These companies have the same main activity as Dr. Thomas Lievens: general medical practice (NACE 86210). They are comparable in size and age: total assets between €141,000 and €170,000, founded in 2021.

Official details

Source: KBO
Status
Active since 29-10-2021Normal situation
Activity
General medical practiceNACE 86210
Establishment unit
2.323.574.7212470 Retie, since 29-10-2021
Financial year end
31 December
Peppol
Reachable since 12-09-2025
Company details

Annual accounts 2025

€151,949▼ 63.5%
Filing
Filed on 29-06-2026, 32 days before the end of the filing period
Financials

Insights on Dr. Thomas Lievens

Dr. Thomas Lievens files the micro format. That format states no turnover. The gross margin rose from €159,043 in 2022 to €182,149 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Thomas Lievens

What is the company number of Dr. Thomas Lievens?
The company number of Dr. Thomas Lievens is 0776.702.061. The VAT number is the same number with BE in front: BE 0776.702.061.
Where is Dr. Thomas Lievens based?
The registered office is at Kievermont 51, 2440 Geel.Company details
What does Dr. Thomas Lievens do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Thomas Lievens?
Dr. Thomas Lievens is a private limited company (BV).
When was Dr. Thomas Lievens founded?
Dr. Thomas Lievens was founded on 29-10-2021.
Is Dr. Thomas Lievens still active?
Yes, Dr. Thomas Lievens is an active enterprise in the KBO register.
What is the turnover of Dr. Thomas Lievens?
The turnover in financial year 2025 is about €330,000. This figure is estimated from the gross margin of €182,149 and 30 comparable companies (NACE 86210). It probably lies between €260,000 and €410,000.Financials
Is Dr. Thomas Lievens profitable?
In financial year 2025, Dr. Thomas Lievens made a profit of €127,350.
Where can I find the annual accounts of Dr. Thomas Lievens?
Dr. Thomas Lievens filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Thomas Lievens due?
Dr. Thomas Lievens must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.